AMASS Brands warns of Nasdaq listing deficiency
AMASS Brands Inc. reported that Nasdaq notified it on July 22, 2026 that the company no longer meets Nasdaq Global Market continued listing requirements based on market value tests.
Rhea-AI Filing Summary
AMASS Brands Inc. reported that Nasdaq notified it on July 22, 2026 that the company no longer meets Nasdaq Global Market continued listing requirements based on market value tests.
For the 30 consecutive business days from June 8 through July 21, 2026, its market value of listed securities was below $50,000,000 and its market value of publicly held shares was below $15,000,000. The notice does not immediately affect trading, and AMASS has 180 calendar days, until January 19, 2027, to regain compliance by meeting both thresholds for at least ten consecutive business days. The company plans to monitor these measures and may seek a transfer to the Nasdaq Capital Market.
Positive
- None.
Negative
- Nasdaq notified AMASS Brands that it is out of compliance with Nasdaq Global Market listing rules after MVLS stayed below $50,000,000 and MVPHS below $15,000,000, creating a risk that its shares could be delisted if compliance is not regained by January 19, 2027.
Filing Explained
Nasdaq may require AMASS to demonstrate compliance for more than the stated ten consecutive business days, generally no more than 20; if compliance is not regained by
8-K Event Classification
Key Figures
Key Terms
market value of the Company’s listed securities financial
continued listing requirements regulatory
Nasdaq Global Market regulatory
Nasdaq Capital Market regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did AMSS receive a Nasdaq deficiency notice on July 22, 2026?
What specific Nasdaq listing rules is AMSS currently failing to satisfy?
How long does AMSS have to regain Nasdaq listing compliance?
What happens if AMSS does not regain compliance with Nasdaq rules by January 19, 2027?
Does the Nasdaq deficiency notice immediately affect trading in AMSS common stock?
What options is AMSS considering to address the Nasdaq listing deficiency?
AI-generated analysis. How Rhea-AI works. Not financial advice.